Target intelligence / Profile preview

Olfactory receptor family 8 subfamily G member 5 (OR8G5)

Target
OR8G5
Molecular classification
G protein-coupled receptor, Receptor, Olfactory receptor, Pseudogene
01

Overview

Olfactory receptor family 8 subfamily G member 5 (OR8G5) is a gene that encodes a member of the large olfactory receptor family involved in the initial detection of odorant molecules in the nasal epithelium, triggering neuronal signals responsible for the perception of smell[1][4]. These proteins are G protein-coupled receptors (GPCRs) with a characteristic seven-transmembrane domain structure, sharing similarities with many neurotransmitter and hormone receptors[1][4]. Notably, multiple authoritative gene and protein databases annotate OR8G5 as a **pseudogene** in humans (frequently referenced as OR8G5P or OR8G5 pseudogene); evidence for protein-level expression or therapeutic relevance is lacking, and no documented drug interactions exist[1][4][5]. Additional context: - The olfactory receptor gene family is the largest in the human genome, and loss-of-function mutations leading to pseudogenization are common[1][6][7]. - While olfactory receptors as a class have been explored for roles beyond smell, such as tumorigenesis or metabolic disease signaling[10], OR8G5 has not been indicated as a therapeutic target, functional receptor, or biomarker for patient selection or efficacy in any disease context. - The various aliases represent historical nomenclature, alternative splicing, or closely related pseudogenes. - Functionally, pseudogenes such as OR8G5 do not produce functional protein due to disruptive mutations, so they generally lack “biological function” and are typically not considered actionable drug targets[1][4][6][11]. In summary, **Olfactory receptor family 8 subfamily G member 5 (OR8G5) is best described in humans as a probable pseudogene, not considered a functional or druggable therapeutic target**. There is no evidence for clinical pharmacology, mechanism of action, biomarker utility, or safety discussion specifically for this receptor in the scientific literature[1][4][6].

Other names
Olfactory receptor 8G5OR8G5POR8G6Olfactory receptor 8G6Olfactory receptor OR11-298OR11-298olfactory receptor 8G6olfactory receptor OR11-298olfactory receptor, family 8, subfamily G, member 5 pseudogeneolfactory receptor, family 8, subfamily G, member 6
02

Biological functions

Signal transductionOlfaction/odor detectionOther
03

Disease associations

Other (Leukoencephalopathy with vanishing white matter association is reported, but not as a primary target)

Beyond the preview

Go deeper on Olfactory receptor family 8 subfamily G member 5 (OR8G5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Olfactory receptor family 8 subfamily G member 5 (OR8G5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call